Shares are trading on the cheap, but are they too risky to touch?
The company reported upbeat quarterly results and boosted full-year guidance.
Shares more than doubled after the gene therapy company announced that it has accepted a buyout offer. Here are the key details.
Shares jump after the company announces a pair of collaborations and a capital raise. Here are the key details.
Shares jump after the company reports upbeat clinical results. Here are the must-know details.
Aesthetics surgery is a big market, and these three companies are positioned to win from its growth.
Exclusive Interview: Livongo Health CEO on Chronic Illness, the U.S. Healthcare System, and Its Opportunity
CEO Zane Burke talks about his company's business model, consumer experience, international expansion, risks, and more.
Looking for values in today's pricey stock market? Start your search with these five businesses.
The rally continues.
The clinical-stage biotech announced wonderful phase 3 results.
Shares slump after a pair of clinical studies raises new questions about the safety and cost effectiveness of Abiomed's family of heart pumps. Here are the must-know details.
Guardant, Dexcom, and Insulet nailed their quarters and have massive room to grow in the long run, too.
Shares pop after news breaks that the company is joining an index. Here are the key details for investors.
Shares jump after the medical device maker announces that it has secured an important regulatory win.
Shares sink after the company announces mixed third-quarter results and issues disappointing guidance.
These companies have a lot to offer their patients and plenty of room to grow.
The stroke prevention specialist is growing rapidly and has a huge opportunity ahead of it. Should investors get on board?
The current transportation process is riddled with inefficiencies and waste. TransMedics is on a mission to fix the problem and deliver huge returns for investors.
The supply chain software provider has grown like a weed over the past decade, but is this company built to last?
How does the supply chain specialist keep rivals at bay?